Scott Thompson, PhD, discusses psychedelic research at CU Anschutz, real-world Colorado psilocybin outcomes, 5-HT2A ...
Conceptual issues, methodological issues, and findings related to long-term risk of dementia with ECT are discussed.
Findings from an analysis of 10 studies suggest lithium is effective in preventing postpartum recurrence of mood disorders.
In this webinar, Balwinder Singh, MD, and Raman Baweja, MD, describe emerging evidence on GLP-1 receptor agonists for ...
Prim Care Companion CNS Disord 2026;28(5):26cr04314. Glucagon-like peptide-1 (GLP-1) receptor agonists are prescribed for type 2 diabetes and obesity due to their effectiveness in improving glycemic ...
The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr ...
To the Editor: On April 18, 2026, President Donald Trump signed an executive order directing the US Food and Drug Administration (FDA) to fast-track review of psychedelic drugs, including psilocybin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results